Technical Analysis for BIOVF - Swedish Orphan Biovi

Grade Last Price % Change Price Change
grade B 16.49 1.73% 0.2800
BIOVF closed up 1.73 percent on Wednesday, December 4, 2019, on 37 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Up
See historical BIOVF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Narrow Range Bar Range Contraction 1.73%
Wide Bands Range Expansion 1.73%
Gapped Down Weakness 1.73%
Narrow Range Bar Range Contraction -1.55%
Wide Bands Range Expansion -1.55%
Gapped Up Strength -1.55%
Up 3 Days in a Row Strength -1.55%

Older signals for BIOVF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B. It also provides Orfadin for the treatment of hereditary tyrosinaemia type 1; and Kineret for the treatment of auto inflammatory condition, as well as Xiapex to treat Dupuytren's contracture and Peyronie's disease. In addition, the company manufactures drug substance for ReFacto AF; and develops BIVV001 and BIVV002 for the treatment of hemophilia. It operates in Sweden, the Middle East, North Africa, Russia, North America, other European countries, and internationally. The company has an agreement with Bioverativ for the development and commercialization of Elocta and Alprolix, as well as XTEN-programs. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.
Biotechnology Medical Specialties RTT Pharmaceuticals Organ Systems Inflammation Hemophilia Haemophilia Haemophilia B Treatment Of Hemophilia Dupuytren's Contracture Swedish Orphan Biovitrum

Is BIOVF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Indicator Value
52 Week High 31.25
52 Week Low 14.2
Average Volume 1,609
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 18.6349
10-Day Moving Average 16.3343
Average True Range 1.2319
ADX 18.0
+DI 44.9000
-DI 55.0542
Chandelier Exit (Long, 3 ATRs ) 25.8043
Chandelier Exit (Short, 3 ATRs ) 18.3357
Upper Bollinger Band 23.8197
Lower Bollinger Band 13.4501
Percent B (%b) 0.29
BandWidth 55.6461
MACD Line -1.3809
MACD Signal Line -1.0738
MACD Histogram -0.3071
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.4900
Resistance 3 (R3) 16.4900 16.4900 16.4900
Resistance 2 (R2) 16.4900 16.4900 16.4900 16.4900
Resistance 1 (R1) 16.4900 16.4900 16.4900 16.4900 16.4900
Pivot Point 16.4900 16.4900 16.4900 16.4900 16.4900
Support 1 (S1) 16.4900 16.4900 16.4900 16.4900 16.4900
Support 2 (S2) 16.4900 16.4900 16.4900 16.4900
Support 3 (S3) 16.4900 16.4900 16.4900
Support 4 (S4) 16.4900